Cross-neutralization Capacity of Immune Serum from Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization against Multiple Individual Polioviruses-Reference-Cited by-同舟云学术

Cross-neutralization Capacity of Immune Serum from Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization against Multiple Individual Polioviruses

Published:2021-05-16 Issue:6 Volume:20 Page:761-767
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Chu Kai¹,Han Weixiao²,Jiang Deyu³,Jiang Zhiwei⁴,Zhu Taotao⁵,Xu Wenbo⁶,Hu Yuemei¹,Zeng Gang²

Affiliation:

1. Department of Vaccine Evaluation, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China

2. Clinical Research Department, Sinovac Biotech Co., Ltd., Beijing, China

3. Center for Research & Department, Sinovac Biotech Co., Ltd.,Beijing, China

4. Statistics department, Beijing Key Tech Statistic Technology Co., Ltd, Beijing

5. Clinical Research Department,Sinovac Biotech Co., Ltd., Beijing China

6. WHO WPRO Regional Reference Measles/Rubella Laboratory, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1919091

Reference33 articles.

1. Global polio eradication initiative. Polio prevention. http://polioeradication.org/polio-today/polio-prevention/. Accessed 2021 Mar 28

2. Polio vaccines: WHO position paper, March 2016–recommendations

3. The polio endgame: securing a world free of all polioviruses

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months;Vaccines;2024-01-25

2. Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months;International Journal of Infectious Diseases;2023-05

3. Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observational study;Vaccine;2023-05

4. Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial;Vaccines;2022-02-08